Acurx Pharmaceuticals, Inc. (ACXP) Social Stream
ACURX PHARMACEUTICALS INC (ACXP) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACXP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-03 | 1 | $12 | $12 | $12 | $4.81 | 149.48% |
| 2022-12-19 | 2 | $14 | $12 | $13 | $4.81 | 170.27% |
| 2023-05-15 | 2 | $14 | $14 | $14 | $4.81 | 191.06% |
| 2023-08-15 | 2 | $13 | $13 | $13 | $4.81 | 170.27% |
| 2023-09-08 | 2 | $13 | $7 | $10 | $4.81 | 107.9% |
| 2023-11-15 | 2 | $13 | $10 | $11.5 | $4.81 | 139.09% |
| 2023-12-15 | 2 | $14 | $10 | $12 | $4.81 | 149.48% |
| NA | 1 | $NA | $NA | $NA | $4.81 | NA% |
The Trend in the Analyst Price Target
Over the past 39 weeks, ACXP's average price target has gone down $2.
Over the past 39 weeks, ACXP's average upside potential has been 353.61%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 2 | 14 | 14 | 14.0 | 3.14 | 345.86% |
| 2023-09-08 | 2 | 13 | 7 | 10.0 | 1.78 | 461.8% |
| 2023-10-13 | 2 | 13 | 10 | 11.5 | 4.34 | 164.98% |
| 2023-11-15 | 2 | 13 | 10 | 11.5 | 3.44 | 234.3% |
| 2023-12-15 | 2 | 14 | 10 | 12.0 | 3.50 | 242.86% |
ACXP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
ACXP's average broker recommendation rating improved by 0 over the prior 122 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how ACURX PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 19.74% of that group.
- ACXP has a lower variance in analysts' estimates than 19.21% of Pharmaceutical Products stocks.
- ACXP has a greater average analyst price target than 170.81% of Healthcare stocks.
- ACXP has a higher upside potential (average analyst target price relative to current price) than 495.16% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ACURX PHARMACEUTICALS INC are HCWB, RNXT, and KTTA.
View All Top Stocks by Price Target
Make investment decisions regarding ACXP using the data that counts. Try POWR Ratings for free.